{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:50:38Z","timestamp":1790614238761,"version":"4.1.0"},"reference-count":200,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1210\/er.2012-1044","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T17:48:16Z","timestamp":1365184096000},"page":"278-301","source":"Crossref","is-referenced-by-count":184,"title":["Nephrogenic Diabetes Insipidus: Essential Insights into the Molecular Background and Potential Therapies for Treatment"],"prefix":"10.1210","volume":"34","author":[{"given":"Hanne B.","family":"Moeller","sequence":"first","affiliation":[{"name":"Department of Biomedicine, Aarhus University, Department of Pediatrics, Aarhus University Hospital, and Center for Interactions of Proteins in Epithelial Transport, Aarhus University, Aarhus 8000, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Rittig","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, Department of Pediatrics, Aarhus University Hospital, and Center for Interactions of Proteins in Epithelial Transport, Aarhus University, Aarhus 8000, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Fenton","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, Department of Pediatrics, Aarhus University Hospital, and Center for Interactions of Proteins in Epithelial Transport, Aarhus University, Aarhus 8000, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"2019041201523887300_B1","first-page":"S20","article-title":"Physiology of ADH secretion. Kidney Int","volume":"21","author":"Robertson","year":"1987","journal-title":"Suppl"},{"key":"2019041201523887300_B2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2400","article-title":"Central mechanisms of osmosensation and systemic osmoregulation","volume":"9","author":"Bourque","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"2019041201523887300_B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol Rev"},{"key":"2019041201523887300_B4","doi-asserted-by":"crossref","first-page":"F257","DOI":"10.1152\/ajprenal.00491.2005","article-title":"Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus","volume":"291","author":"Robben","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrendo.2011.100","article-title":"Familial forms of diabetes insipidus: clinical and molecular characteristics","volume":"7","author":"Babey","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2019041201523887300_B6","doi-asserted-by":"crossref","first-page":"32248","DOI":"10.1074\/jbc.274.45.32248","article-title":"Association of \u03b2-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization","volume":"274","author":"Oakley","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","article-title":"Diabetes insipidus","volume":"24","author":"Robertson","year":"1995","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041201523887300_B8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4158\/EP09090.RA","article-title":"Diabetes insipidus in pregnancy: etiology, evaluation, and management","volume":"15","author":"Ananthakrishnan","year":"2009","journal-title":"Endocr Pract"},{"key":"2019041201523887300_B9","doi-asserted-by":"crossref","first-page":"790281","DOI":"10.1155\/2012\/790281","article-title":"Membrane protein stability analyses by means of protein energy profiles in case of nephrogenic diabetes insipidus","volume":"2012","author":"Heinke","year":"2012","journal-title":"Comput Math Methods Med"},{"key":"2019041201523887300_B10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.me.39.020188.002233","article-title":"Differential diagnosis of polyuria","volume":"39","author":"Robertson","year":"1988","journal-title":"Annu Rev Med"},{"key":"2019041201523887300_B11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.1997.00440330027003","article-title":"The management of diabetes insipidus in adults","volume":"157","author":"Singer","year":"1997","journal-title":"Arch Intern Med"},{"key":"2019041201523887300_B13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3949\/ccjm.73.1.65","article-title":"Diabetes insipidus: diagnosis and treatment of a complex disease","volume":"73","author":"Makaryus","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"2019041201523887300_B14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM198112243052601","article-title":"A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria","volume":"305","author":"Zerbe","year":"1981","journal-title":"N Engl J Med"},{"key":"2019041201523887300_B15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1148\/radiology.207.1.9530302","article-title":"Posterior lobe of the pituitary gland: correlation between signal intensity on T1-weighted MR images and vasopressin concentration","volume":"207","author":"Kurokawa","year":"1998","journal-title":"Radiology"},{"key":"2019041201523887300_B16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2008.03513.x","article-title":"Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus","volume":"71","author":"Ranadive","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041201523887300_B17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"2019041201523887300_B18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semnephrol.2006.03.003","article-title":"Familial neurohypophyseal diabetes insipidus\u2014an update","volume":"26","author":"Christensen","year":"2006","journal-title":"Semin Nephrol"},{"key":"2019041201523887300_B19","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1152\/physrev.2001.81.3.1197","article-title":"Gene regulation in the magnocellular hypothalamo-neurohypophysial system","volume":"81","author":"Burbach","year":"2001","journal-title":"Physiol Rev"},{"key":"2019041201523887300_B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The human gene mutation database: 2008 update","volume":"1","author":"Stenson","year":"2009","journal-title":"Genome Med"},{"key":"2019041201523887300_B21","first-page":"754","article-title":"Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus","volume":"22","author":"Arima","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"2019041201523887300_B22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/8.7.1303","article-title":"Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin","volume":"8","author":"Willcutts","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2019041201523887300_B23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-09-0772","article-title":"Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy","volume":"162","author":"Abu Libdeh","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041201523887300_B24","first-page":"341A","article-title":"A Novel X-linked form of familial neurophpophyseal diabetes insipidus","volume":"44","author":"Habiby","year":"1996","journal-title":"J Invest Med"},{"key":"2019041201523887300_B25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1096\/fj.99-0892fje","article-title":"Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene","volume":"14","author":"Si-Hoe","year":"2000","journal-title":"FASEB J"},{"issue":"Pt 21","key":"2019041201523887300_B26","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1242\/jcs.051136","article-title":"Dominant pro-vasopressin mutants that cause diabetes insipidus form disulfide-linked fibrillar aggregates in the endoplasmic reticulum","volume":"122","author":"Birk","year":"2009","journal-title":"J Cell Sci"},{"key":"2019041201523887300_B27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI119357","article-title":"Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum","volume":"99","author":"Ito","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B28","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1074\/jbc.274.13.9029","article-title":"Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins","volume":"274","author":"Ito","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B29","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI200318616","article-title":"A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons","volume":"112","author":"Russell","year":"2003","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B30","doi-asserted-by":"crossref","first-page":"R1641","DOI":"10.1152\/ajpregu.00034.2009","article-title":"Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus","volume":"296","author":"Hayashi","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2019041201523887300_B31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/ajplegacy.1964.206.2.425","article-title":"Familial hypothalamic diabetes insipidus in rats (Brattleboro strain)","volume":"206","author":"Valtin","year":"1964","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/308705a0","article-title":"Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats","volume":"308","author":"Schmale","year":"1984","journal-title":"Nature"},{"key":"2019041201523887300_B33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.V8121863","article-title":"Arginine vasopressin secretion with mutants of wild-type and Brattleboro rats AVP gene","volume":"8","author":"Kim","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B34","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1073\/pnas.91.19.8984","article-title":"Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat","volume":"91","author":"DiGiovanni","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"2019041201523887300_B35","first-page":"F414","article-title":"Long-term regulation of four renal aquaporins in rats","volume":"271","author":"Terris","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00424-008-0612-4","article-title":"Essential role of vasopressin-regulated urea transport processes in the mammalian kidney","volume":"458","author":"Fenton","year":"2009","journal-title":"Pflugers Arch"},{"key":"2019041201523887300_B37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1152\/physrev.00053.2006","article-title":"Mouse models and the urinary concentrating mechanism in the new millennium","volume":"87","author":"Fenton","year":"2007","journal-title":"Physiol Rev"},{"key":"2019041201523887300_B38","doi-asserted-by":"crossref","first-page":"p23","DOI":"10.1159\/000320117","article-title":"Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases","volume":"116","author":"Bockenhauer","year":"2010","journal-title":"Nephron Physiol"},{"key":"2019041201523887300_B39","first-page":"2183","article-title":"Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol","volume":"27","author":"Wesche","year":"2012","journal-title":"2012"},{"key":"2019041201523887300_B40","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.V1091958","article-title":"Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus","volume":"10","author":"van Lieburg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","article-title":"Nephrogenic diabetes insipidus","volume":"13","author":"Bichet","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"2019041201523887300_B42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.semnephrol.2006.02.004","article-title":"Hereditary polyuric disorders: new concepts and differential diagnosis","volume":"26","author":"Bichet","year":"2006","journal-title":"Semin Nephrol"},{"key":"2019041201523887300_B43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"2019041201523887300_B44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.0.1560223","article-title":"Structural bases of vasopressin\/oxytocin receptor function","volume":"156","author":"Barberis","year":"1998","journal-title":"J Endocrinol"},{"key":"2019041201523887300_B45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/psc.714","article-title":"Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(\u03b1) systems","volume":"12","author":"Slusarz","year":"2006","journal-title":"J Pept Sci"},{"key":"2019041201523887300_B46","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm051075m","article-title":"Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors","volume":"49","author":"Slusarz","year":"2006","journal-title":"J Med Chem"},{"key":"2019041201523887300_B47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/359233a0","article-title":"Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus","volume":"359","author":"Rosenthal","year":"1992","journal-title":"Nature"},{"key":"2019041201523887300_B48","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s004670100051","article-title":"Molecular and cellular defects in nephrogenic diabetes insipidus","volume":"16","author":"Knoers","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"2019041201523887300_B49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1507\/endocrj.K07-083","article-title":"Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations","volume":"55","author":"Satoh","year":"2008","journal-title":"Endocr J"},{"key":"2019041201523887300_B51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/00365599.2010.482946","article-title":"Skewed X-chromosome inactivation causing diagnostic misinterpretation in congenital nephrogenic diabetes insipidus","volume":"44","author":"Faerch","year":"2010","journal-title":"Scand J Urol Nephrol"},{"key":"2019041201523887300_B52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semnephrol.2008.03.005","article-title":"Vasopressin receptor mutations in nephrogenic diabetes insipidus","volume":"28","author":"Bichet","year":"2008","journal-title":"Semin Nephrol"},{"key":"2019041201523887300_B53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcp.21552","article-title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance","volume":"217","author":"Spanakis","year":"2008","journal-title":"J Cell Physiol"},{"key":"2019041201523887300_B54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ajmg.a.31536","article-title":"Contiguous gene deletion involving L1CAM and AVPR2 causes X-linked hydrocephalus with nephrogenic diabetes insipidus","volume":"143","author":"Tegay","year":"2007","journal-title":"Am J Med Genet A"},{"key":"2019041201523887300_B55","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ajmg.a.32386","article-title":"Nephrogenic diabetes insipidus in a patient with L1 syndrome: a new report of a contiguous gene deletion syndrome including L1CAM and AVPR2","volume":"146A","author":"Knops","year":"2008","journal-title":"Am J Med Genet A"},{"key":"2019041201523887300_B56","doi-asserted-by":"crossref","first-page":"937175","DOI":"10.1155\/2012\/937175","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"2012","author":"Morin","year":"2012","journal-title":"Int J Pediatr"},{"key":"2019041201523887300_B57","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"352","author":"Feldman","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041201523887300_B58","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1210\/jc.2009-2524","article-title":"Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2 and vasopressin excretion","volume":"95","author":"Ranchin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041201523887300_B59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2006090987","article-title":"Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree","volume":"18","author":"Decaux","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00467-006-0344-7","article-title":"Hyponatremia resulting from arginine vasopressin receptor 2 gene mutation","volume":"22","author":"Bes","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"2019041201523887300_B61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-09-0246","article-title":"Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis","volume":"161","author":"Gupta","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2019041201523887300_B62","doi-asserted-by":"crossref","first-page":"431527","DOI":"10.1186\/1687-9856-2009-431527","article-title":"Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis","author":"Cho","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"2019041201523887300_B63","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s00467-008-0913-z","article-title":"Neonatal onset of nephrogenic syndrome of inappropriate antidiuresis","volume":"23","author":"Marcialis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"2019041201523887300_B64","doi-asserted-by":"crossref","first-page":"e8383","DOI":"10.1371\/journal.pone.0008383","article-title":"The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation","volume":"4","author":"Tenenbaum","year":"2009","journal-title":"PLoS One"},{"key":"2019041201523887300_B65","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1538-7836.2010.03884.x","article-title":"Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels","volume":"8","author":"Nossent","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2019041201523887300_B66","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI9154","article-title":"Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene","volume":"106","author":"Yun","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B67","doi-asserted-by":"crossref","first-page":"F1177","DOI":"10.1152\/ajprenal.00465.2007","article-title":"V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis","volume":"295","author":"Schliebe","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B68","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","article-title":"A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus","volume":"119","author":"Li","year":"2009","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B69","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","article-title":"Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype","volume":"9","author":"Ala","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B70","doi-asserted-by":"crossref","first-page":"p1","DOI":"10.1159\/000245059","article-title":"Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus","volume":"114","author":"Bockenhauer","year":"2009","journal-title":"Nephron Physiol"},{"key":"2019041201523887300_B71","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.109.061804","article-title":"Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments","volume":"77","author":"Rochdi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"2019041201523887300_B72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:24:1:055","article-title":"Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus","volume":"24","author":"Mizuno","year":"2004","journal-title":"Endocrine"},{"key":"2019041201523887300_B73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.2007.03054.x","article-title":"Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene","volume":"68","author":"Faerch","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041201523887300_B74","first-page":"58A","article-title":"The cause of vasopressin responsive familial diabetes insipidus in a large Swedish kindred with X-linked recessive mode of transmission","volume":"49","author":"Robertson","year":"2001","journal-title":"J Invest Med"},{"key":"2019041201523887300_B75","first-page":"555A","article-title":"A newly recognized variant of familial nephrogenic diabetes insipidus distinguished by partial resistance to vasopressin (type II)","volume":"29","author":"Robertson","year":"1981","journal-title":"Clin Res"},{"key":"2019041201523887300_B76","first-page":"11","article-title":"Variations in clinical phenotype associated with different mutations of the V2 receptor gene in X-linked recessive congenital nephrogenic DI (xCNDI)","author":"Robertson"},{"key":"2019041201523887300_B77","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2012.01.005","article-title":"Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature","volume":"61","author":"Neocleous","year":"2012","journal-title":"Metabolism"},{"key":"2019041201523887300_B78","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/hmg\/6.11.1865","article-title":"Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response","volume":"6","author":"Canfield","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2019041201523887300_B79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1681\/ASN.V82242","article-title":"New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels","volume":"8","author":"Mulders","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B80","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2005010104","article-title":"Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2\u2013R254L explains dominant nephrogenic diabetes insipidus","volume":"16","author":"de Mattia","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B81","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1002\/humu.21082","article-title":"p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation","volume":"30","author":"Savelkoul","year":"2009","journal-title":"Hum Mutat"},{"key":"2019041201523887300_B82","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1097\/01.ASN.0000027355.41663.14","article-title":"Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus","volume":"13","author":"Marr","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B83","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/323643","article-title":"Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus","volume":"69","author":"Kuwahara","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2019041201523887300_B84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI2605","article-title":"An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex","volume":"102","author":"Mulders","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B85","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1172\/JCI117079","article-title":"Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct","volume":"93","author":"Sasaki","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B86","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jmb.2005.04.030","article-title":"The 4.5 A structure of human AQP2","volume":"350","author":"Schenk","year":"2005","journal-title":"J Mol Biol"},{"key":"2019041201523887300_B87","doi-asserted-by":"crossref","first-page":"F1062","DOI":"10.1152\/ajprenal.00721.2010","article-title":"Regulation of the water channel aquaporin-2 by posttranslational modification","volume":"300","author":"Moeller","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B88","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.0600895103","article-title":"Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites","volume":"103","author":"Hoffert","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B89","doi-asserted-by":"crossref","first-page":"14800","DOI":"10.1074\/jbc.272.23.14800","article-title":"Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel","volume":"272","author":"Fushimi","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B90","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.151.4.919","article-title":"The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers","volume":"151","author":"Kamsteeg","year":"2000","journal-title":"J Cell Biol"},{"issue":"Pt 2","key":"2019041201523887300_B91","first-page":"F817","article-title":"Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells","volume":"272","author":"Katsura","year":"1997","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2008.505","article-title":"Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells","volume":"75","author":"Moeller","year":"2009","journal-title":"Kidney Int"},{"key":"2019041201523887300_B93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1073\/pnas.0910683107","article-title":"Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions","volume":"107","author":"Moeller","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B94","doi-asserted-by":"crossref","first-page":"24617","DOI":"10.1074\/jbc.M803074200","article-title":"Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2","volume":"283","author":"Hoffert","year":"2008","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B95","first-page":"648","article-title":"Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene","volume":"55","author":"van Lieburg","year":"1994","journal-title":"Am J Hum Genet"},{"key":"2019041201523887300_B96","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.0511324103","article-title":"Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice","volume":"103","author":"Rojek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B97","doi-asserted-by":"crossref","first-page":"F465","DOI":"10.1152\/ajprenal.00494.2005","article-title":"Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deleltion","volume":"291","author":"Yang","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B98","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.080499597","article-title":"Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels","volume":"97","author":"Ma","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B99","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1074\/jbc.273.8.4296","article-title":"Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels","volume":"273","author":"Ma","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B100","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1074\/jbc.M008216200","article-title":"Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus","volume":"276","author":"Yang","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B101","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.08-118422","article-title":"Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation","volume":"23","author":"Yang","year":"2009","journal-title":"FASEB J"},{"key":"2019041201523887300_B102","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pgen.0010020","article-title":"Diabetes insipidus in mice with a mutation in aquaporin-2","volume":"1","author":"Lloyd","year":"2005","journal-title":"PLoS Genet"},{"key":"2019041201523887300_B103","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1172\/JCI117920","article-title":"Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing","volume":"95","author":"Deen","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B104","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8140421","article-title":"Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine","volume":"264","author":"Deen","year":"1994","journal-title":"Science"},{"key":"2019041201523887300_B105","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1210\/jcem.87.6.8617","article-title":"Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families","volume":"87","author":"Lin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041201523887300_B106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004240000498","article-title":"Functionality of aquaporin-2 missense mutants in recessive nephrogenic diabetes insipidus","volume":"442","author":"Marr","year":"2001","journal-title":"Pflugers Arch"},{"issue":"Pt 12","key":"2019041201523887300_B107","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1113\/jphysiol.2010.187674","article-title":"New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytes","volume":"588","author":"Leduc-Nadeau","year":"2010","journal-title":"J Physiol"},{"key":"2019041201523887300_B108","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1083\/jcb.200309017","article-title":"Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus","volume":"163","author":"Kamsteeg","year":"2003","journal-title":"J Cell Biol"},{"key":"2019041201523887300_B109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1113\/expphysiol.2008.043000","article-title":"Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?","volume":"94","author":"Boone","year":"2009","journal-title":"Exp Physiol"},{"key":"2019041201523887300_B110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/humu.21068","article-title":"Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus","volume":"30","author":"Kamsteeg","year":"2009","journal-title":"Hum Mutat"},{"key":"2019041201523887300_B111","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1073\/pnas.0602331103","article-title":"Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation","volume":"103","author":"Sohara","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-540-79885-9_5","article-title":"Aquaporins in the kidney","volume":"190","author":"Kwon","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"2019041201523887300_B113","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: a systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2019041201523887300_B114","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Gr\u00fcnfeld","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"2019041201523887300_B115","doi-asserted-by":"crossref","first-page":"F812","DOI":"10.1152\/ajprenal.00554.2007","article-title":"Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus","volume":"294","author":"Bedford","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B116","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/183891a0","article-title":"Animal physiology: chlorothiazide in diabetes insipidus","volume":"183","author":"Crawford","year":"1959","journal-title":"Nature"},{"key":"2019041201523887300_B117","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ki.2009.91","article-title":"Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus","volume":"76","author":"Kortenoeven","year":"2009","journal-title":"Kidney Int"},{"key":"2019041201523887300_B118","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1681\/ASN.2010070734","article-title":"\u03b1ENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus","volume":"22","author":"Christensen","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B119","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1172\/JCI111901","article-title":"Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats","volume":"75","author":"Christensen","year":"1985","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B120","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.2000.279.3.F552","article-title":"Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI","volume":"279","author":"Kwon","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B121","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1172\/JCI117863","article-title":"Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla","volume":"95","author":"Marples","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B122","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2005080884","article-title":"Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity","volume":"17","author":"Li","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B123","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0272-6386(87)80098-7","article-title":"Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy","volume":"10","author":"Boton","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"2019041201523887300_B124","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1073\/pnas.0800001105","article-title":"Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation","volume":"105","author":"Nielsen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"2019041201523887300_B125","first-page":"F1080","article-title":"Mechanisms of lithium-vasopressin interaction in rabbit cortical collecting tubule","volume":"252","author":"Cogan","year":"1987","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B126","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1172\/JCI112465","article-title":"Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit","volume":"77","author":"Cogan","year":"1986","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B127","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00383.2005","article-title":"Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct","volume":"291","author":"Christensen","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B128","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00266.2003","article-title":"Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI","volume":"286","author":"Christensen","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"2019041201523887300_B129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.1965.03090030059024","article-title":"Nephrogenic diabetes insipidus due to demethylchlortetracycline hydrochloride","volume":"193","author":"Castell","year":"1965","journal-title":"JAMA"},{"key":"2019041201523887300_B130","first-page":"420","article-title":"Nephrogenic diabetes insipidus induced by demethylchlortetracycline (Declomycin)","volume":"107","author":"Torin","year":"1967","journal-title":"Calif Med"},{"key":"2019041201523887300_B131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinte.1967.04410010047006","article-title":"Nephrotoxicity of demethylchlortetracycline hydrochloride. A prospective study","volume":"120","author":"Roth","year":"1967","journal-title":"Arch Intern Med"},{"key":"2019041201523887300_B132","doi-asserted-by":"crossref","first-page":"679","DOI":"10.7326\/0003-4819-79-5-679","article-title":"Demeclocycline-induced nephrogenic diabetes insipidus. In-vivo and in-vitro studies","volume":"79","author":"Singer","year":"1973","journal-title":"Ann Intern Med"},{"key":"2019041201523887300_B133","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7326\/0003-4819-83-5-654","article-title":"Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion","volume":"83","author":"Cherrill","year":"1975","journal-title":"Ann Intern Med"},{"key":"2019041201523887300_B134","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0272-6386(96)90369-8","article-title":"Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy","volume":"27","author":"Navarro","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2019041201523887300_B135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1592\/phco.29.5.613","article-title":"Nephrogenic diabetes insipidus induced by two amphotericin B liposomal formulations","volume":"29","author":"Metzger","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2019041201523887300_B136","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mpo.10336","article-title":"Chronic ifosfamide nephrotoxicity in children","volume":"41","author":"Skinner","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"2019041201523887300_B137","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1172\/JCI118628","article-title":"Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex","volume":"97","author":"Marples","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B138","doi-asserted-by":"crossref","first-page":"F1313","DOI":"10.1152\/ajprenal.00040.2002","article-title":"AQP3, p-AQP2, and AQP2 expression is reduced in polyuric rats with hypercalcemia: prevention by cAMP-PDE inhibitors","volume":"283","author":"Wang","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Pt 2","key":"2019041201523887300_B139","first-page":"F978","article-title":"Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats","volume":"274","author":"Sands","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B140","doi-asserted-by":"crossref","first-page":"F1416","DOI":"10.1152\/ajprenal.00421.2005","article-title":"Hypokalemia in a mouse model of Gitelman's syndrome","volume":"290","author":"Morris","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B141","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/2230-8210.85596","article-title":"Nephrogenic diabetes insipidus with idiopathic Fanconi's syndrome in a child who presented as vitamin D resistant rickets","volume":"15","author":"Patra","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"2019041201523887300_B142","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00044.2003","article-title":"Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia","volume":"286","author":"Wang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B143","doi-asserted-by":"crossref","first-page":"F1376","DOI":"10.1152\/ajprenal.00186.2002","article-title":"Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats","volume":"283","author":"Elkjaer","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B144","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2007010092","article-title":"Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism","volume":"19","author":"Bustamante","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"issue":"Pt 2","key":"2019041201523887300_B146","first-page":"F611","article-title":"Localization of the extracellular Ca2+\/polyvalent cation-sensing protein in rat kidney","volume":"274","author":"Riccardi","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B147","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1523-1755.2004.66036.x","article-title":"Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells","volume":"66","author":"Procino","year":"2004","journal-title":"Kidney Int"},{"key":"2019041201523887300_B148","doi-asserted-by":"crossref","first-page":"e33145","DOI":"10.1371\/journal.pone.0033145","article-title":"Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study","volume":"7","author":"Procino","year":"2012","journal-title":"PLoS One"},{"key":"2019041201523887300_B149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-291X(03)00215-8","article-title":"Calpain-mediated AQP2 proteolysis in inner medullary collecting duct","volume":"303","author":"Puliyanda","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041201523887300_B150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/bjs.1800810504","article-title":"Ischaemia-reperfusion injury","volume":"81","author":"Grace","year":"1994","journal-title":"Br J Surg"},{"key":"2019041201523887300_B151","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bjs.1800830206","article-title":"Renal ischaemia\u2013reperfusion injury","volume":"83","author":"Weight","year":"1996","journal-title":"Br J Surg"},{"key":"2019041201523887300_B152","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1213\/00000539-199401000-00023","article-title":"Association of preoperative risk factors with postoperative acute renal failure","volume":"78","author":"Novis","year":"1994","journal-title":"Anesth Analg"},{"key":"2019041201523887300_B153","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1053-0770(98)90106-9","article-title":"Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies","volume":"12","author":"Aronson","year":"1998","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2019041201523887300_B154","first-page":"632","article-title":"The cell biology of reperfusion injury in the kidney","volume":"42","author":"Paller","year":"1994","journal-title":"J Investig Med"},{"key":"2019041201523887300_B155","first-page":"F17","article-title":"Isolated nephron segments in a rabbit model of ischemic acute renal failure","volume":"239","author":"Hanley","year":"1980","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B156","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.1973.134","article-title":"Effects of renal artery occlusion on kidney function in the rat","volume":"4","author":"Tanner","year":"1973","journal-title":"Kidney Int"},{"key":"2019041201523887300_B157","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ki.1978.87","article-title":"Ischemic damage and repair in the rat proximal tubule: differences among the S1, S2, and S3 segments","volume":"14","author":"Venkatachalam","year":"1978","journal-title":"Kidney Int"},{"issue":"Pt 2","key":"2019041201523887300_B158","first-page":"F413","article-title":"Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by \u03b1-MSH","volume":"277","author":"Kwon","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B159","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1681\/ASN.V1081658","article-title":"Decreased abundance of collecting duct aquaporins in post-ischemic renal failure in rats","volume":"10","author":"Fern\u00e1ndez-Llama","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B160","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/ndt\/gfg377","article-title":"Reduced renal expression of AQP2, p-AQP2 and AQP3 in haemorrhagic shock-induced acute renal failure","volume":"18","author":"Gong","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2019041201523887300_B161","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196905222802101","article-title":"Vasopressin-resistant hyposthenuria in advanced chronic renal disease","volume":"280","author":"Tannen","year":"1969","journal-title":"N Engl J Med"},{"key":"2019041201523887300_B162","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI118044","article-title":"Vasopressin resistance in chronic renal failure. Evidence for the role of decreased V2 receptor mRNA","volume":"96","author":"Teitelbaum","year":"1995","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"2019041201523887300_B163","first-page":"F724","article-title":"Reduced AQP1, -2, and -3 levels in kidneys of rats with CRF induced by surgical reduction in renal mass","volume":"275","author":"Kwon","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B164","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM197603042941001","article-title":"DDAVP in the treatment of central diabetes insipidus","volume":"294","author":"Robinson","year":"1976","journal-title":"N Engl J Med"},{"key":"2019041201523887300_B165","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm1297-1402","article-title":"Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin","volume":"3","author":"Geddes","year":"1997","journal-title":"Nat Med"},{"key":"2019041201523887300_B166","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ymthe.2003.08.019","article-title":"Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats","volume":"8","author":"Ideno","year":"2003","journal-title":"Mol Ther"},{"issue":"Pt 1","key":"2019041201523887300_B167","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1525-0016(03)00069-8","article-title":"Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin","volume":"7","author":"Bienemann","year":"2003","journal-title":"Mol Ther"},{"key":"2019041201523887300_B168","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/en.2003-0366","article-title":"Gene therapy for central diabetes insipidus: effective antidiuresis by muscle-targeted gene transfer","volume":"145","author":"Yoshida","year":"2004","journal-title":"Endocrinology"},{"key":"2019041201523887300_B169","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/adc.80.6.548","article-title":"Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride","volume":"80","author":"Kirchlechner","year":"1999","journal-title":"Arch Dis Child"},{"key":"2019041201523887300_B170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000166896","article-title":"Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus","volume":"5","author":"Alon","year":"1985","journal-title":"Am J Nephrol"},{"key":"2019041201523887300_B171","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3476(05)81106-0","article-title":"Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus","volume":"117","author":"Knoers","year":"1990","journal-title":"J Pediatr"},{"key":"2019041201523887300_B172","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1097\/01.ASN.0000143476.93376.04","article-title":"Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel","volume":"15","author":"Kim","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B173","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00467-005-2057-8","article-title":"Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus","volume":"20","author":"Soylu","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"2019041201523887300_B174","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00467-003-1195-0","article-title":"Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor","volume":"18","author":"Pattaragarn","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"2019041201523887300_B175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1620\/tjem.162.137","article-title":"A family case of nephrogenic diabetes insipidus","volume":"162","author":"Okayasu","year":"1990","journal-title":"Tohoku J Exp Med"},{"key":"2019041201523887300_B176","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2265.1998.00426.x","article-title":"Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency","volume":"49","author":"Hochberg","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041201523887300_B177","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1651-2227.1994.tb13072.x","article-title":"Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus","volume":"83","author":"Jakobsson","year":"1994","journal-title":"Acta Paediatr"},{"key":"2019041201523887300_B178","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00247.2006","article-title":"Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus","volume":"292","author":"Robben","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B179","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2826.2010.01983.x","article-title":"Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus","volume":"22","author":"Los","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"2019041201523887300_B180","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B181","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B182","doi-asserted-by":"crossref","first-page":"47254","DOI":"10.1074\/jbc.M408154200","article-title":"Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors","volume":"279","author":"W\u00fcller","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041201523887300_B183","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI116554","article-title":"Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors","volume":"92","author":"Serradeil-Le Gal","year":"1993","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B184","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/me.2004-0080","article-title":"Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059","volume":"18","author":"Bernier","year":"2004","journal-title":"Mol Endocrinol"},{"key":"2019041201523887300_B185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B186","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B187","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.semnephrol.2008.03.010","article-title":"Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus","volume":"28","author":"Bouley","year":"2008","journal-title":"Semin Nephrol"},{"key":"2019041201523887300_B188","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1172\/JCI9594","article-title":"Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells","volume":"106","author":"Bouley","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041201523887300_B189","doi-asserted-by":"crossref","first-page":"F530","DOI":"10.1152\/ajprenal.00070.2005","article-title":"Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking","volume":"290","author":"Wang","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B190","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00337.2004","article-title":"Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)","volume":"288","author":"Bouley","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B191","doi-asserted-by":"crossref","first-page":"F216","DOI":"10.1152\/ajprenal.00439.2010","article-title":"Sildenafil reduces polyuria in rats with lithium-induced NDI","volume":"302","author":"Sanches","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B192","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000186196","article-title":"Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus","volume":"56","author":"Bichet","year":"1990","journal-title":"Nephron"},{"key":"2019041201523887300_B193","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2009121267","article-title":"Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration","volume":"22","author":"Bouley","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2019041201523887300_B194","first-page":"F506","article-title":"Effects of calcitonin on the renal concentrating mechanism","volume":"245","author":"de Rouffignac","year":"1983","journal-title":"Am J Physiol"},{"key":"2019041201523887300_B195","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00001.2011","article-title":"Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase","volume":"301","author":"Li","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B196","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00424-011-1007-5","article-title":"Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells","volume":"462","author":"Procino","year":"2011","journal-title":"Pflugers Arch"},{"key":"2019041201523887300_B197","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1073\/pnas.1104691108","article-title":"Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus","volume":"108","author":"Olesen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041201523887300_B198","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1471-0528.2003.00016.x","article-title":"ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women","volume":"111","author":"Steinwall","year":"2004","journal-title":"BJOG"},{"key":"2019041201523887300_B199","doi-asserted-by":"crossref","first-page":"F1334","DOI":"10.1152\/ajprenal.00308.2006","article-title":"Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2","volume":"292","author":"Shi","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041201523887300_B200","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1073\/pnas.0602087103","article-title":"Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation","volume":"103","author":"McDill","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/34\/2\/278\/8859365\/edrv0278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T04:44:52Z","timestamp":1644727492000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/34\/2\/278\/2354632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":200,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,1,29]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2012-1044","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}